Browse Contents
Special Offers
SCImago Journal Ranking
| Forthcoming Special Issues |
Applications of gold nanoparticles(GNPs) in cancer managementsGuest Editor(s): Ali Yadollahpour Tentative Publication Date: May, 2017 Submit Abstract via Email Download Description |
| Special Issues - In-Press |
| Please visit again after some time to view these Issues. |
| Published Special Issues |
The Use Of Positron Emission Tomography In External Beam Therapy Dose PlanningCurrent Radiopharmaceuticals, Volume 8, Number 1 Guest Editor(s): Kalevi Kairemo |
Current Radiopharmaceuticals
,Volume 11
-Number 2
Biography Open Access
Meet Our Regional Editor
Review Article
Motion Management in PET/CT: Technological Solutions
, 11(2): 79 - 85Elena De Ponti, Sabrina Morzenti*, Cinzia Crivellaro, Federica Elisei, Andrea Crespi and Luca Guerra
DOI: 10.2174/1874471011666180419150440
Motion Management in PET/CT: Technological Solutions
Research Article
PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors
, 11(2): 86 - 91Pierpaolo Alongi*, Leonardo Iaccarino , Marco Losa, Antonella del Vecchio, Simonetta Gerevini, Valentina Plebani, Nadia Di Muzio , Pietro Mortini , Luigi Gianolli and Daniela Perani
DOI: 10.2174/1874471011666180525134301
PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors
Research Article
Modeling of a Cyclotron Target for the Production of 11C with Geant4
, 11(2): 92 - 99Andrea Chiappiniello*, Federico Zagni, Angelo Infantino, Sara Vichi, Gianfranco Cicoria, Maria Pia Morigi and Mario Marengo
DOI: 10.2174/1874471011666180412170219
Modeling of a Cyclotron Target for the Production of 11C with Geant4
Research Article
Development and Evaluation of Liquid and Solid Lipid Based Drug Delivery Systems Containing Technetium-99m-Radiolabeled Alendronate Sodium
, 11(2): 100 - 108Evren Gundogdu*, Meliha Ekinci, Emre Ozgenc, Derya I. Ozdemir and Makbule Asikoglu
DOI: 10.2174/1874471011666180529111914
Development and Evaluation of Liquid and Solid Lipid Based Drug Delivery Systems Containing Technetium-99m-Radiolabeled Alendronate Sodium
Research Article
Radioprotective Effect of Cerium Oxide Nanoparticles Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
, 11(2): 109 - 115Zohreh Zal, Arash Ghasemi, Shima Azizi, Hossein Asgarian-Omran, Azadeh Montazeri and Seyed Jalal Hosseinimehr*
DOI: 10.2174/1874471011666180528095203
Radioprotective Effect of Cerium Oxide Nanoparticles Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
Research Article
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation
, 11(2): 116 - 122Nafise Salek*, Sara Vosoghi, Simindokht S. Arani, Ali B. Samani, Mohsen Mehrabi and Mohammad G. Maraghe
DOI: 10.2174/1874471011666180412165722
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation
Research Article
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
Current Radiopharmaceuticals, Volume 11 (2018) - Number 3
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage
Pierpaolo Alongi*, Ignazio Gaspare Vetrano, Elisa Fiasconaro, Valerio Alaimo, Riccardo Laudicella, Marina Bellavia, Francesca Rubino, Sergio Bagnato and Giuseppe Galardi
View Abstract View on PubMed
Evaluating the Radioprotective Effect of Curcumin on Rat’s Heart Tissues
Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa
View Abstract View on PubMed
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
I Kreimerman, E Mora-Ramirez , A. L Reyes, M Bardies , E Savio * and H Engler
View Abstract
Abstracts Ahead of Print
Determination of gamma camera’s calibration factors for quantitation of diagnostic radionuclides in simultaneous scattering and attenuation correction
Afrouz Asgari, Mansour Ashoor, Leila Sarkhosh, Abdollah Khorshidi* and Parvaneh Shokrani
View Abstract
Editor's Choice
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 2018; 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34 - 45Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Personalized & Precision Medicine in Cancer: A Theranostic Approach
, 2017; 10(3): 166 - 170Partha Choudhury* and Manoj Gupta
DOI: 10.2174/1874471010666170728094008
PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
, 2017; 10(3): 184 - 194Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*
DOI: 10.2174/1874471010666170816125051
β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors
, 2017; 10(2): 93 - 101Piyush Kumar*, Peter Roselt, Gerald Reischl, Carlene Cullinane, Davood Beiki, Walter Ehrlichmann, David Binns, Ebrahim Naimi, Jennifer Yang, Rodney Hicks, Hans-Juergen Machulla and Leonard I. Wiebe
DOI: 10.2174/1874471010666170313120540
Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders
, 2017; 10(2): 115 - 122Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer
DOI: 10.2174/1874471010666170621122221
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
, 2017; 10(1): 21 - 28Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Roger Chammas, Eloisa Riva, Juan Pablo Gambini and Pablo Cabral
DOI: 10.2174/1874471009666161010155246
Radiolabeled Sugars Used for PET and SPECT Imaging
, 2016; 9(3): 180 - 186Brianda Barrios-Lopez and Kim Bergstrom
DOI: 10.2174/1874471008666150525104725
Radioguided Surgery for Localization of Nonpalpable Breast Lesions A Mini-Review
, 2016; 9(2): 114 - 120Linnea Langhans, Thomas Levin Klausen, Tove Filtenborg Tvedskov, Ilse Vejborg, Niels Kroman and Birger Hesse
DOI: 10.2174/1874471009999160625105340
Theranostic Applications of Lutetium-177 in Radionuclide Therapy
, 2016; 9(1): 94 - 101Tapas Das and Sharmila Banerjee
DOI: 10.2174/1874471008666150313114644
Open Access Articles
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
, 2018; 11(3): 200 - 208Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
, 2018; 11(3): 156 - 172Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
, 2018; 11: 1 - 9 (E-Pub Ahead of Print)I Kreimerman, E Mora-Ramirez , A. L Reyes, M Bardies , E Savio * and H Engler
Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101
, 2017; 10(3): 212 - 220Ingrid Kreimerman, Williams Porcal, Silvia Olivera, Patricia Oliver, Eduardo Savio* and Henry Engler
Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine
, 2017; 10(3): 203 - 211Florencia Zoppolo, Williams Porcal, Patricia Oliver, Eduardo Savio* and Henry Engler
Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders
, 2017; 10(2): 115 - 122Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer
Gallium-68 in Medical Imaging
, 2016; 9(3): 187 - 207Lucia Martiniova, Louis De Palatis, Elba Etchebehere and Gregory Ravizzini
Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
, 2013; 6(1): 20 - 27Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle
Targeted α-Particle Therapy: A Clinical Overview
, 2008; 1(3): 251 - 253Massimo Salvatori, Luca Indovina and Luigi Mansi
Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
, 2008; 1(3): 203 - 208Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen
Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study
, 2008; 1(2): 62 - 64Maria Picchio, C. Messa, B. Giglioni, F. Sanvito, E. Caporizzo, C. Landoni, G. Arrigoni, A. Carretta, R. Nicoletti, P. Zannini, A. Del Maschio and F. Fazio
Asymmetric Synthesis of L-[3-13C]Tryptophan
, 2008; 1(2): 122 - 124Kazuhiko Takatori, Myonghui Lee and Masahiro Kajiwara
Synthesis of 1-Amino-2-[3-13C]propanol Hydrochloride: Completion of Synthetic Methods for all of its 13C- and 15N-Isotopomers
, 2008; 1(2): 120 - 121K. Iida, Y. Nakajima and M. Kajiwara
Most Cited Articles
Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
, 2016; 9(1): 44-53.Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S. Jhanwar, Gurveen Kaur, Scott T. Tagawa, David M. Nanus, Neil H. Bander and Stanley J. Goldsmith
DOI: 10.2174/1874471008666150313114005
Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with 177Lu and Conjugated to Peptides
, 2015; 8(2): 150-159.Guillermina Ferro-Flores, Blanca E. Ocampo-García, Clara L. Santos-Cuevas, Flor de María Ramírez, Erika P. Azorín-Vega and Laura Meléndez-Alafort
DOI: 10.2174/1874471008666150313115423
Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine
, 2015; 8(2): 78-85.Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp
DOI: 10.2174/1874471008666150312155959
Indirect Production of No Carrier Added (NCA) 177Lu from Irradiation of Enriched 176Yb: Options for Ytterbium/Lutetium Separation
, 2015; 8(2): 107-118.Ashutosh Dash, Rubel Chakravarty, Furn F. (Russ) Knapp and Ambikalmajan M.R. Pillai
DOI: 10.2174/1874471008666150312161942
Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)
, 2016; 9(1): 6-7.Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp
DOI: 10.2174/187447100901151123124826
Theranostic Applications of Lutetium-177 in Radionuclide Therapy
, 2016; 9(1): 94-101.Tapas Das and Sharmila Banerjee
DOI: 10.2174/1874471008666150313114644
Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176
, 2015; 8(2): 95-106.Valery A. Tarasov, Oleg I. Andreev, Evgeny G. Romanov, Rostislav A. Kuznetsov, Vladimir V. Kupriyanov and Ivan V. Tselishchev
DOI: 10.2174/1874471008666150312160855
Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
, 2016; 9(1): 8-18.Wouter A.P. Breeman, Ho Sze Chan, Rory M.S. de Zanger, Mark K. Konijnenberg and Erik de Blois
DOI: 10.2174/1874471008666150313111131
Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT
, 2015; 8(1): 19-31.Finn Edler von Eyben, Kalevi Kairemo, Timo Kiljunen and Timo Joensuu
DOI: 10.2174/1874471008666150316222203
Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis
, 2016; 9(2): 137-142.María Elena Cardoso, Leticia Fernández, Emilia Tejería, Patricia Esperón and Mariella Terán
DOI: 10.2174/1874471009666160215162023
Most Accessed Articles
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma
, 2018; 11(1): 14-21.Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*
DOI: 10.2174/1874471011666171215093112
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
, 2018; 11(3): 200-208.Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
DOI: 10.2174/1874471011666180502104524
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34-45.Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications
, 2018; 11(1): 4-13.Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello
DOI: 10.2174/1874471010666171101121803
Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
, 2018; 11(1): 22-33.Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore
DOI: 10.2174/1874471011666171211161851
Letter to the Editor: International Consensus Radiochemistry Nomenclature Guidelines
, 2018; 11(1): 73-75.Heinz H. Coenen*, Antony D. Gee*, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike and Albert D. Windhorst
DOI: 10.2174/187447101101180404111248
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer–A Single Institution Experience
, 2018; 11(2): 147-152.Kalevi Kairemo, Denai R. Milton, Elba Etchebehere, Eric M. Rohren and Homer A. Macapinlac*
DOI: 10.2174/1874471011666180629145030
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry
, 2018; 11(1): 50-57.Paola Mapelli, Valentino Bettinardi, Federico Fallanca, Elena Incerti, Antonia Compierchio, Francesca Rossetti, Angela Coliva, Annarita Savi, Claudio Doglioni, Giampiero Negri, Luigi Gianolli and Maria Picchio*
DOI: 10.2174/1874471010666171108162319
PET Radiopharmaceuticals in Brazil and Belarus: Economic Comparison Using the Case of 18FDG
, 2018; 11(1): 69-72.Sviatoslav Brinkevich, Leonardo Paredes Pires, Filipe Leal Portilho and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666171211164111
Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-18F-Fluorohippuric Acid and Ortho-124I-Iodohippuric Acid from Rat Biodistribution Data
, 2018; 11(1): 58-63.Mohsen Cheki*, Maryam Papie, Luigi Mansi, Sean Kitson and Hariprasad Gali
DOI: 10.2174/1874471011666180212123534
Webmaster Contact: info@benthamscience.org